Arnhold, J. (2004). Properties, functions, and secretion of human myeloperoxidase. Biochemistry, 69(1), 4–9.
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014). Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity, 2014, 360438.
Buldukoglu, O. C., Ocal, S., Akca, S., Atar, G. E., Kaya, B., Isik, M. D., Koca, O., Harmandar, F. A., Cekin, Y., & Cekin, A. H. (2025). A novel inflammatory biomarker in assessing disease activity in ulcerative colitis: gasdermin D. BMC Gastroenterology, 25(1), 418.
Bulek, K., Zhao, J., Liao, Y., Rana, N., Corridoni, D., Antanaviciute, A., Chen, X., Wang, H., Qian, W., Miller-Little, W. A., Swaidani, S., Tang, F., Willard, B. B., McCrae, K., Kang, Z., Dubyak, G. R., Cominelli, F., Simmons, A., Pizarro, T. T., & Li, X. (2020). Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis. Journal of Clinical Investigation, 130(8), 4218–4234.
Chen, P., Zhou, G., Lin, J., Li, L., Zeng, Z., Chen, M., & Zhang, S. (2020). Serum biomarkers for inflammatory bowel disease. Frontiers in Medicine, 7, 123.
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013). Interleukin-18 and IL-18 binding protein. Frontiers in Immunology, 4, 289.
Gao, X., Wang, C., Shen, X.-T., Li, C.-Y., Li, Y.-C., Gao, H., Qian, J.-M., & Zhang, X.-L. (2023). Pyroptosis burden is associated with anti-TNF treatment outcome in inflammatory bowel disease: new insights from bioinformatics analysis. Scientific Reports, 13(1), 15821.
Kaplanski, G., Dinarello, C. A., & Bongrand, P. (2003). Interleukin-18 and interleukin-1beta: Two cytokine substrates for ICE (caspase-1). Journal of Clinical Immunology, 23(1), 1–11.
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., Liu, P. S., Lill, J. R., Li, H., Wu, J., Kummerfeld, S., Zhang, J., Lee, W. P., Snipas, S. J., Salvesen, G. S., … Dixit, V. M. (2015). Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature, 526(7575), 666–671.
Krzystek-Korpacka, M., Kempiński, R., Bromke, M. A., & Neubauer, K. (2020). Oxidative stress markers in inflammatory bowel diseases: Systematic review. Diagnostics, 10(8), 601.
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2021). Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature, 535(7610), 153–158.
Ma, Z. R., Li, Y., & Yang, J. (2023). Inhibition of GSDMD-mediated pyroptosis attenuates colitis (Trichinella spiralis model). Parasites and Vectors, 16(1), 280.
Magro, F., Doherty, G., Peyrin-Biroulet, L., Svrcek, M., Borralho, P., Walsh, A., Carneiro, F., Rosini, F., de Hertogh, G., Biedermann, L., Pouillon, L., Scharl, M., Tripathi, M., Danese, S., Villanacci, V., & Feakins, R. (2020). ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology. Journal of Crohn’s and Colitis, 14(11), 1503–1511.
Parry, A., Smith, S., & Jones, P. (2022). Biomarker panels in IBD: Combining inflammation and oxidative stress markers improves diagnostic accuracy. Clinical and Translational Gastroenterology, 13(3), e00402.
Rathkey, J. K., Zhao, J., Liu, Z., Chen, Y., Yang, J., Kondolf, H. C., ... & Li, X. (2018). Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Science Immunology, 3(26), eaat2738.
Seven, A., Aslan, M., Incir, S., & Altıntaş, A. (2021). Evaluation of oxidative and nitrosative stress in patients with ulcerative colitis: A case-control study. Arab Journal of Gastroenterology, 22(2), 106–110.
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015). Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature, 526(7575), 660–665.
Singh, S., Ananthakrishnan, A. N., Nguyen, N. H., & Feuerstein, J. D. (2023). AGA clinical practice guideline on the role of biomarkers for management of Crohn's disease (and related biomarker guidance). Gastroenterology, 165(6), 1367–1399.
Zhou, B., Zhang, J. Y., Liu, X. S., Chen, H. Z., Ai, Y. L., Cheng, K., Sun, R. Y., Zhou, D., Han, J., & Wu, Q. (2018). Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Research, 28(12), 1171–1185.
Comments (0)